Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0–2-month-old low birth weight infants in India—the “ProSPoNS” Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial

BACKGROUND: Progress has been made in the reduction of under-five mortality in India; however, neonatal mortality is reducing at a slower rate. Efforts are required to bring down neonatal mortality in order to attain the Sustainable Development Goal-3. Prevention of sepsis among the high-risk, vulne...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Anju Pradhan, Gupta, Subodh S., Poluru, Ramesh, Raut, Abhishek V., Arora, Narendra Kumar, Pandey, Ravindra Mohan, Sahu, Aditya Ranjan, Bethou, Adhisivam, Sazawal, Sunil, Parida, Sailajanandan, Bavdekar, Ashish, Saili, Arvind, Gaind, Rajni, Kapil, Arti, Garg, Bishan S., Maliye, Chetna, Jain, Manish, Mahajan, Kamlesh S., Dhingra, Pratibha, Pradhan, Keshab C., Kawade, Anand S., Nangia, Sushma, Mukherjee, Ajit, Rasaily, Reeta, Sharma, Radhey Shyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017823/
https://www.ncbi.nlm.nih.gov/pubmed/33794969
http://dx.doi.org/10.1186/s13063-021-05193-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017823/
https://www.ncbi.nlm.nih.gov/pubmed/33794969
http://dx.doi.org/10.1186/s13063-021-05193-w

Ejemplares similares